Barclays raised target for Danaher stock to USD 255.00

Published on 10/12/2026 at 12:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Danaher posted USD 6.26 billion revenue in the second quarter of 2026, up 5.50 percent year over year. Danaher stock costs EUR 196.25 on October 12, 2026.

Key points in brief

Barclays raised its Danaher price target from USD 230.00 to USD 255.00.
Danaher announced an AI-powered autonomous lab targeting up to 8x faster discovery and 10x reagent output.
Danaher stock was at EUR 196.25 at Lang & Schwarz on October 12, 2026 at 12:02 p.m. CEST.
Third-quarter 2026 earnings are scheduled for October 21, 2026.

Flatlay mit Aktienzertifikat, ISIN-Karte US2358511028, Pipetten und Laborutensilien auf weißem Marmor — Danaher Corp. Aktien-Zertifikat und ISIN-Karte US2358511028 im Flatlay mit Laborutensilien auf weißem Marmor, Illustration mit AI erstellt.

Danaher Corp. stock (ISIN US2358511028) was at EUR 196.25 at Lang & Schwarz on October 12, 2026 at 12:02 p.m. CEST. MarketBeat reported that Barclays raised its Danaher target from USD 230.00 to USD 255.00 in a note dated October 7, 2026, while maintaining an overweight rating.

Three events shape the stock

On July 21, 2026, Danaher reported second-quarter 2026 results with revenue of USD 6.26 billion, according to its investor-relations release page. MarketBeat said adjusted earnings per share reached USD 1.94 versus consensus of USD 1.85, while revenue increased 5.50 percent year over year.

On October 1, 2026, Julie Sawyer Montgomery assumed the roles of president and chief executive officer, as listed by Danaher. The latest event came on October 7, 2026, when the company announced an autonomous laboratory designed to accelerate antibody and molecular-tool discovery.

What does the AI lab mean for Danaher?

PR Newswire reported on October 7, 2026 that the lab is expected to operate at scale in early 2027. Danaher said the design targets up to 8x faster progress from idea to validated reagent and up to a tenfold increase in annual reagent generation.

The laboratory will be based at Abcam and combine artificial intelligence, robotics and technologies from several Danaher businesses. That gives the announcement a measurable operating ambition, but the figures are forward-looking targets rather than reported revenue or profit.

Dates for the next catalyst

Danaher has scheduled its third-quarter 2026 earnings conference call for October 21, 2026 at 8:00 a.m. ET, according to Danaher. The company also set October 30, 2026 as the payment date for its USD 0.40 quarterly dividend.

At Lang & Schwarz, Danaher stock was trading at EUR 196.25 on October 12, 2026 at 12:02 p.m. CEST. The latest structured market data put Danaher's market capitalization at USD 154.6 billion on October 9, 2026, with a 52-week range of USD 160.93 to USD 242.80.

The further course of trading is shown by the continuously updated real-time quote of Danaher stock.